vaccine immune response
Scope
Date
~
-
Korean startups
Despite liquidity crunch, 5 verticals rake in venture capital investment
The global venture capital ecosystem has been contracting since the second quarter of last year, hit by rising inflation and rate hikes. New ...
Oct 13, 2022 (Gmt+09:00)
-
Shareholder value
Samsung leader Lee calls on mgt to raise shareholder value
Samsung Electronics Co. set up a task force team dedicated to increasing its shareholder value last month, according to industry sources on Oct. 4. ...
Oct 04, 2022 (Gmt+09:00)
-
COVID-19
SK Bioscience seeks WHO nod for prompt COVID vaccine sale
SK Bioscience Co., the biopharmaceutical unit of South Korea’s No. 2 conglomerate SK Group, sought approval from the World Health Organization...
Sep 08, 2022 (Gmt+09:00)
-
Samsung Group
Samsung Elec. unveils Odyssey Ark, 55-inch curved gaming screen
Samsung Electronics Co. on Monday announced the global launch of Odyssey Ark, the world’s first 55-inch 1000R curved gaming screen. 100...
Aug 16, 2022 (Gmt+09:00)
-
Corporate investment
Korea to raise cash support on foreign investments in key sectors
South Korea plans to spend more cash on attracting foreign investments in high-tech and core supply chain industries as foreign direct investment to...
Jul 18, 2022 (Gmt+09:00)
-
Bio & Pharma
Orion enters China’s vaccine market with tuberculosis plant in Jining
Orion Holdings Corp., one of South Korea’s largest confectionery companies, said on Wednesday it will build a vaccine plant in China by 2024 t...
Jul 13, 2022 (Gmt+09:00)
language -
Bio & Pharma
SK Bioscience wins marketing license for Korea's first COVID-19 vaccine
South Korea’s SK Bioscience Co., a biopharmaceutical unit of SK Group, has won marketing authorization for its COVID-19 vaccine from the Minis...
Jun 29, 2022 (Gmt+09:00)
language -
The KED View
Who should be held accountable for BTS label's stock plunge?
K-pop sensation BTS’ decision to temporarily split up and launch solo careers was made known after a pre-recorded video came out Wednesday of ...
Jun 16, 2022 (Gmt+09:00)
-
North Korea
North Korea missile tests drawing tougher response from US, South Korea
SEOUL—The U.S. and South Korea are responding to North Korea’s unprecedented number of missile tests this year with a greater show of ...
Jun 13, 2022 (Gmt+09:00)
-
Bio & Pharma
Korean drugmakers close to commercializing COVID-19 vaccine, pill
South Korea’s biopharmaceutical companies are close to commercializing a COVID-19 vaccine and treatment pill as they are on the brink of compl...
Apr 25, 2022 (Gmt+09:00)
-
Bio & Pharma
SK Bioscience seeks multi-billion-dollar M&As, eyes gene therapy sector
SK Bioscience Co., the biopharmaceutical unit of South Korea’s SK Group, is seeking multi-billion-dollar mergers and acquisitions to expand it...
Mar 31, 2022 (Gmt+09:00)
-
Bio & Pharma
SK Bioscience becomes first to win domestic COVID-19 vaccine contract
SK Bioscience Co. said it reached a deal with Korea’s disease control agency to supply 10 million doses of the country’s first experimen...
Mar 22, 2022 (Gmt+09:00)
language -
Earnings
SK Bioscience posts record earnings driven by COVID-19 vaccines
SK Bioscience Co., a biopharmaceutical unit of South Korea’s SK Group, has posted record 2021 revenue and operating profit, boosted by contrac...
Feb 08, 2022 (Gmt+09:00)
-
COVID-19
SK Bioscience to sell Novavax COVID-19 vaccine in Thailand, Vietnam
SK Bioscience Co., a biopharmaceutical unit of South Korea’s SK Group, said on Friday it has acquired non-exclusive rights to sell US-based No...
Dec 24, 2021 (Gmt+09:00)
language -
COVID-19
Korea approves export of Samsung Biologics-made Moderna vaccine
South Korea approved exports of Moderna Inc.’s COVID-19 vaccine produced by Samsung Biologics Co. in a move that will help the country’s...
Dec 14, 2021 (Gmt+09:00)
language -
Business & Politics
Jay Y. Lee meets Verizon CEO and Moderna co-founder
Samsung Electronics Co. Vice Chairman Jay Y. Lee has met with biopharmaceutical conglomerate Moderna’s co-founder and telecommunications g...
Nov 18, 2021 (Gmt+09:00)
language -
Business & Politics
Samsung heir Lee on US trip for foundry investment, COVID vaccines
Jay Y. Lee, vice chairman and de facto leader of South Korea’s top conglomerate Samsung, has embarked on a business trip to North America to f...
Nov 14, 2021 (Gmt+09:00)
-
Shareholder activism
SK Chem says no immediate plan to sell SK Bioscience stake
SK Chemicals Co., the top shareholder of South Korea's SK Bioscience Co., is not considering reducing its stake in the vaccine maker in the immediat...
Nov 02, 2021 (Gmt+09:00)
-
COVID-19
Samsung Biologics-made Moderna vaccine available to Koreans this week
Moderna Inc.’s COVID-19 vaccine first produced by Samsung Biologics Co. under a contract manufacturing organization (CMO) service will be avai...
Oct 27, 2021 (Gmt+09:00)
language -
Moderna co-founder
Giving away patents not in line with capitalist society
WASHINGTON D.C. -- US-based biotechnology company Moderna Inc. wasn’t a household name until the beginning of last year, when its fate changed...
Oct 12, 2021 (Gmt+09:00)
-
Food & Beverage
KGC creates Ginseng Museum Cafe in New York
Korea Ginseng Corporation (KGC), a wholly-owned subsidiary of KT&G Corporation, has set up its first interactive cafe in the global market where...
Sep 17, 2021 (Gmt+09:00)
-
Asia’s Covid-19 Success Stories Warily Ponder Post-Vaccination Moves
Earlier this month, Singapore reached a Covid-19 milestone: The fully vaccinated portion of the population crossed 80%. But instead of moving ahead wi...
Sep 15, 2021 (Gmt+09:00)
-
COVID-19
Samsung Biologics gears up to produce mRNA drug substance
South Korea’s Samsung Biologics Co. is gearing up for the drug substance (DS) sector of the messenger ribonucleic acid (mRNA)-based COVID-19 v...
Sep 01, 2021 (Gmt+09:00)
language -
Mergers & Acquisitions
Interpark draws cool response from Korean online giants
South Korea’s online retail platform Interpark Corp. has failed to drum up interest from the country's largest online platforms, including Nav...
Aug 31, 2021 (Gmt+09:00)
-
Hydrogen economy
Hyundai Mobis to invest $1.1 bn to make hydrogen fuel cells
Hyundai Motor Group’s long-term ambition to create a full-fledged hydrogen value chain, from fuel cell production to hydrogen-powered logist...
Aug 20, 2021 (Gmt+09:00)
-
COVID-19
SK Bioscience to kick off phase 3 vaccine trials
SK Bioscience Co. has received approval from South Korea’s Ministry of Food and Drug Safety (MFDS) for phase 3 clinical trials of its COVID-19...
Aug 10, 2021 (Gmt+09:00)
language -
Batteries
SK's battery unit split-off drives polarized responses
The share price of South Korea's SK Innovation Co. has extended losses following its confirmation on Tuesday of the battery business splif-off plan,...
Aug 06, 2021 (Gmt+09:00)
-
COVID-19
Korean govt to spend $1.9 billion to become world’s leading vaccine maker
The South Korean government will invest 2.2 trillion won ($1.9 billion) by 2025 to become a top five vaccine producer in the world. President Moon J...
Aug 05, 2021 (Gmt+09:00)
-
COVID-19
War for bio talent intensifies as S.Korea works on mRNA vaccines
As concerns rise over a resurgence of the COVID-19 pandemic, the war for talent in South Korea’s pharmaceutical industry is intensifying as th...
Aug 05, 2021 (Gmt+09:00)
-
IPOs
Market Kurly's IPO plans dwarfed by SSG.COM's IPO talk
Kurly Inc., which runs South Korea's online grocery delivery service Market Kurly, has tentatively halted its IPO process, about a month after it an...
Aug 03, 2021 (Gmt+09:00)
Latest News
- 1 Maybe Happy Ending: How a Seoul-made robot love story rewrote Broadway playbook
- 2 NPS yet to schedule external manager selection; PE firms’ fundraising woes deepen
- 3 Woori Financial wins approval for Tongyang, ABL Life acquisition
- 4 BMW surpasses Mercedes in Korean sales amid imported vehicle market shake-up
- 5 Seoul appeal: Korean art captivates Indonesia’s affluent connoisseurs